Watch Ticker

Lantheus Holdings, Inc

Go to Lantheus Holdings, Inc Website

$73.15

1.69 (2.36%)

Live

Previous Close

$71.46

Day Range

$71.2268 - $73.41

Previous Day Range

$70.05 - $71.58

Market Cap

$4.9 billion USD

Day Vol.

495013

Previous Day Vol.

1.1 million

Currency

USD

Primary Exchange

Nasdaq

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Lantheus Holdings, Inc. - Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D

Lantheus has successfully acquired Life Molecular Imaging and appointed Dr. Ludger Dinkelborg as Head of R&D. The acquisition includes Neuraceq®, an FDA-approved PET imaging agent for Alzheimer's disease detection, and provides Lantheus with advanced R&D capabilities and international presence.

Related tickers: LNTH.

Read Full Article

N/A - Radiopharmaceuticals Market Products and Applications Report 2025 | SPECT Radiopharmaceuticals Lead Diagnostic Market with 67% Share

The global radiopharmaceuticals market is projected to grow at a CAGR of 10.3% from 2024 to 2030, driven by the increasing prevalence of chronic diseases, advancements in imaging technology, and the transition towards personalized medicine. North America and Asia-Pacific are the key regional markets.

Related tickers: ATNM, DRTS, DRTSW, BAYRY, CAH, LLY, GEHC, LNTH, NVS, SMMNY, TLX.

Read Full Article

Trending Tickers

Please sign in to view